Clinical trial

Increasing Germline Genetic Testing for Patients With Cancer

NCT07307664

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-01-30

PhaseNA

Study timeline

Study start (actual)2026-01-30Date precision: day

Registry last updated2026-06-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hereditary Pancreatic Cancerunresolved

Conditions or Focus of Studyunresolved

Hereditary Breast Cancerunresolved

Hereditary Colorectal Cancerunresolved

Interventions

Implementation strategiesBEHAVIORAL

Sponsors & collaborators

Josh Petersonlead sponsor

National Human Genome Research Institute (NHGRI)collaborator

National Cancer Institute (NCI)collaborator

Mapped research locations

ChicagoIllinois, United States1 Los AngelesCalifornia, United States1 NashvilleTennessee, United States1 DurhamNorth Carolina, United States1 IndianapolisIndiana, United States1 OrlandoFlorida, United States1 Salt Lake CityUtah, United States1 DecaturGeorgia, United States1 DanvillePennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07307664 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.